Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine infusion for refractory visual hallucinations in Parkinson's disease
2016-000102-11Phase 2Active
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Apomorphine infusion with Placebo infusion (2 arms). Primary endpoint: Change in clinical global impression of severity of visual hallucinations. Started Nov 2016; status: active.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2016-000102-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000102-11.